Schering-Plough Corp. will acquire Organon BioSciences N.V., the human and animal health care businesses of Akzo Nobel N.V., for approximately $14.4 billion in cash. The transaction is expected to close by the end of 2007. “With this transaction we take another major step in our action agenda to transform SP into a global high-performance company for the long term,” said Fred Hassan, SP’s chairman and chief executive officer. “It is the right deal at the right time as we...